Ardelyx, Inc.

Ownership Transactions Reported by 22 Insiders

Symbol
ARDX on Nasdaq
Industry
Pharmaceutical Preparations
Location
34175 Ardenwood Blvd., Fremont, CA

Insiders trading volume in the past year

Ardelyx, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Forest Baskett 10%+ Owner $15M Dec 9, 2021
Scott D. Sandell 10%+ Owner $15M Dec 9, 2021
David Mott Director $10.1M +$3.37M +50.3% Feb 24, 2025
Michael Raab President & CEO, Director $8.43M -$3.05M -26.5% Apr 4, 2025
Susan Rodriguez Chief Commercial Officer $3.84M -$52.4K -1.34% May 21, 2024
Justin Renz Chief Financial Officer $2.59M -$126K -4.63% Feb 25, 2025
David Rosenbaum Chief Development Officer $2.52M -$1.2M -32.3% Nov 20, 2024
Laura A. Williams Chief Medical Officer $2.41M -$1.51M -38.5% Feb 25, 2025
Elizabeth Grammer Chief Legal and Administrative Officer $2.06M -$3.08M -59.9% Feb 25, 2025
Eric D. Foster Chief Commercial Officer $2.06M Feb 25, 2025
Mike Kelliher Executive Vice President, Corporate Development and Strategy $1.96M Feb 25, 2025
Robert Blanks Chief Regulatory and Quality Affairs Officer $1.84M -$317K -14.7% Nov 20, 2024
William C. Bertrand JR Director $1.62M Jun 14, 2024
Jan M. Lundberg Director $1.09M Jun 15, 2023
Jeffrey W. Jacobs Chief Scientific Officer $793K Nov 22, 2021
Robert Ora Felsch SVP Finance and Chief Accounting Officer $722K -$1.88M -72.2% Aug 20, 2024
Joseph J. Reilly Officer $554K Nov 15, 2024
Richard J. Rodgers Director $193K Jan 16, 2025
Geoffrey A. Block Director $114K Jun 15, 2023
Robert B. Bazemore Director $93.4K Jun 14, 2024
Onaiza Cadoret-Manier Director $93.4K Jun 14, 2024
Muna Bhanji Director $93.4K Jun 14, 2024

Recent Insider Transactions by Companies or Individuals for Ardelyx, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.